T. Rowe Price Associates’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63K | Buy |
11,869
+248
| +2% | +$1.32K | ﹤0.01% | 2972 |
|
|
2025
Q1 | $95K | Buy |
11,621
+1,617
| +16% | +$13.2K | ﹤0.01% | 2826 |
|
|
2024
Q4 | $129K | Sell |
10,004
-9,796
| -49% | -$126K | ﹤0.01% | 2787 |
|
|
2024
Q3 | $213K | Sell |
19,800
-255
| -1% | -$2.74K | ﹤0.01% | 2631 |
|
|
2024
Q2 | $159K | Buy |
20,055
+5,596
| +39% | +$44.4K | ﹤0.01% | 2651 |
|
|
2024
Q1 | $232K | Buy |
14,459
+1,117
| +8% | +$17.9K | ﹤0.01% | 2546 |
|
|
2023
Q4 | $184K | Buy |
13,342
+200
| +2% | +$2.76K | ﹤0.01% | 2569 |
|
|
2023
Q3 | $193K | Sell |
13,142
-957
| -7% | -$14.1K | ﹤0.01% | 2511 |
|
|
2023
Q2 | $240K | Buy |
14,099
+3,499
| +33% | +$59.6K | ﹤0.01% | 2460 |
|
|
2023
Q1 | $149K | Sell |
10,600
-4,500
| -30% | -$63.3K | ﹤0.01% | 2594 |
|
|
2022
Q4 | $100K | Hold |
15,100
| – | – | ﹤0.01% | 2718 |
|
|
2022
Q3 | $80K | Buy |
+15,100
| New | +$80K | ﹤0.01% | 2770 |
|
|
2022
Q2 | – | Sell |
-11,290
| Closed | -$96K | – | 2996 |
|
|
2022
Q1 | $96K | Buy |
+11,290
| New | +$96K | ﹤0.01% | 2844 |
|